<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>81(13)</volume><submitter>Jin R</submitter><funding>NIDDK NIH HHS</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><journal>The Prostate</journal><pagination>944-955</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8750893</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.</pubmed_title><pmcid>PMC8750893</pmcid><funding_grant_id>R01 DK115477</funding_grant_id><funding_grant_id>5R01 DK111554</funding_grant_id><funding_grant_id>R01 DK111554</funding_grant_id><funding_grant_id>U54 DK104310</funding_grant_id><pubmed_authors>Ramirez-Solano M</pubmed_authors><pubmed_authors>Matusik RJ</pubmed_authors><pubmed_authors>Jin R</pubmed_authors><pubmed_authors>Case T</pubmed_authors><pubmed_authors>Cates JMM</pubmed_authors><pubmed_authors>Sanchez S</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Strand DW</pubmed_authors><pubmed_authors>Milne GL</pubmed_authors><pubmed_authors>Miller NL</pubmed_authors><pubmed_authors>Bjorling DE</pubmed_authors><pubmed_authors>Forbes CM</pubmed_authors><pubmed_authors>Wang ZY</pubmed_authors></additional><is_claimable>false</is_claimable><name>The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.</name><description/><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-22T21:12:13.955Z</modification><creation>2025-04-22T21:12:13.955Z</creation></dates><accession>S-EPMC8750893</accession><cross_references><pubmed>34288015</pubmed><doi>10.1002/pros.24190</doi></cross_references></HashMap>